Biotech News

The Ensign Group Schedules First Quarter 2026 Earnings Call for Friday, May 1, 2026

Ensign Group (ENSG)Ensign GroupEarnings

The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it expects to issue its first quarter 2026 financial results on Thursday, April 30, 2026.

Conference Call

Ensign invites current and prospective investors to tune into a live webcast to be held the following day, Friday, May 1, 2026, at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time), during which Ensign's management will discuss Ensign's first quarter 2026 performance.

To listen to the webcast, or to view any financial or other statistical information required by SEC Regulation G, please visit the Investors section of the Ensign website at http://investor.ensigngroup.net. The webcast will be recorded and will be available for replay via the website until 5:00 p.m. Pacific time on Friday, May 29, 2026.

About Ensign™

The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 378 healthcare facilities in Alabama, Alaska, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. More information about Ensign is available at http://www.ensigngroup.net.

Contact Information The Ensign Group, Inc., (949) 487-9500, [email protected].

SOURCE: The Ensign Group, Inc.

Related news

Ensign Group

Post-Acute Care Operating Platform The Ensign Group operates skilled nursing, senior living, rehabilitation, and other post-acute care services through independent subsidiaries across multiple U.S. states. Performance depends on decentralized local management, facility quality, and reimbursement conditions across government and...

Recent company news

Stock data

Close
179.48 USD
Market cap
9.68B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States